Join date: Oct 1, 2020
Apr 7, 2022 ∙ 5 min
NeuroSigma Announces MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD
NeuroSigma Announces King’s College London Team Receives MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD to...
Feb 22, 2022 ∙ 3 min
NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®
LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA...